Table 1. Pathways that are commonly enriched in PrECs exposed to 5 nM BPA, 25 nM BPA and 0.1 nM EE2. Orange: pathways related to metabolism pathways, green: pathways related to DNA replication and cell cycle, yellow: pathways related to cancer, light blue: pathways related to inflammation and immune response, purple: pathways related to protein biogenesis, dark green: signaling pathways, pink: pathways related to biological adhesion. (The color version of the table is available in the electronic copy of the article).
Pathways Common to All 3 Exposures |
5 nM BPA
(p-value) |
25 nM BPA
(p-value) |
0.1 nM EE2
(p-value) |
---|---|---|---|
Alanine, aspartate and glutamate metabolism | 5.11E-03 | 1.07E-02 | 9.81E-03 |
Biosynthesis of amino acids | 1.36E-04 | 8.12E-04 | 1.70E-03 |
Carbon metabolism | 2.98E-05 | 1.82E-04 | 1.04E-03 |
Cell cycle | 9.63E-04 | 1.82E-03 | 1.37E-02 |
Central carbon metabolism in cancer | 6.05E-04 | 1.01E-02 | 6.84E-03 |
Chemical carcinogenesis | 2.68E-03 | 7.53E-03 | 3.01E-02 |
Cytokine-cytokine receptor interaction | 5.00E-03 | 2.97E-03 | 1.22E-02 |
DNA replication | 3.88E-06 | 1.56E-08 | 1.46E-07 |
ECM-receptor interaction | 5.28E-06 | 6.99E-06 | 4.75E-04 |
HTLV-I infection | 2.67E-03 | 1.69E-03 | 2.86E-03 |
Leukocyte transendothelial migration | 4.34E-02 | 1.81E-02 | 3.71E-02 |
Metabolic pathways | 5.32E-03 | 1.39E-03 | 4.28E-04 |
Mismatch repair | 3.63E-02 | 4.50E-04 | 7.97E-05 |
Natural killer cell mediated cytotoxicity | 1.60E-02 | 3.43E-02 | 4.87E-02 |
Protein digestion and absorption | 4.46E-03 | 3.00E-03 | 3.44E-02 |
Proteoglycans in cancer | 1.12E-02 | 1.06E-02 | 6.08E-03 |
Purine metabolism | 1.20E-02 | 2.28E-04 | 6.75E-04 |
Pyrimidine metabolism | 6.38E-03 | 1.06E-03 | 3.82E-03 |
Regulation of actin cytoskeleton | 3.32E-02 | 2.24E-02 | 2.58E-02 |
Ribosome biogenesis in eukaryotes | 6.62E-04 | 1.01E-03 | 1.28E-02 |
RNA transport | 2.28E-02 | 3.28E-02 | 2.45E-02 |
Small cell lung cancer | 4.79E-02 | 1.74E-02 | 1.70E-02 |
TGF-beta signaling pathway | 4.30E-02 | 3.21E-02 | 4.19E-02 |